Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Aesthetic Devices Pipeline Market Report Overview

Aesthetic devices refer to the devices that are used in cosmetic procedures for beautification, correction and improvement of body contour which includes fillers, breast implants, facial implants and penile implants. The Aesthetic devices pipeline market research report provides comprehensive information about the aesthetic devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Aesthetic Injectables

·       Hyaluronic Acid Fillers

·       Aesthetic Laser

·       Implants

·       Others

Key Territories ·       United States

·       Europe

·       China

·       South Korea

·       Others

Key Regulatory Paths ·       510(k)

·       CE

·       PMA

·       NMPA

·       NIFDS

·       TGA

·       HSA

·       ICAC

·       ANVISA

·       BOPA

·       Ninsho

·       MDITAC

·       MDL

·       MDA

·       MDCO

·       INVIMA

·       UKCA

·       Shonin

Leading Companies ·       3D Bio Corp

·       AbbVie Inc

·       Allergan Aesthetics

·       Candela Corp

·       Dexlevo

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Aesthetic Devices Pipeline Market Segments

Some of the key segments in the aesthetic devices pipeline market are aesthetic injectables, implants, hyaluronic acid fillers, aesthetic laser, and others. As of May 2023, aesthetic injectables has the highest share.

Aesthetic Devices Pipeline Market Analysis, by Segments, 2023 (%)

Aesthetic Devices Pipeline Market Analysis, by Segments, 2023 (%)

For more segment insights into the aesthetic devices pipeline market, download a free report sample

Aesthetic Devices Pipeline Market Segmentation by Territories

Some key territories with aesthetic devices products in the pipeline are the US, China, South Korea, Israel, and Australia among others. As of May 2023, the US had the highest number of products in the pipeline compared to the other territories.

Aesthetic Devices Pipeline Market Analysis, by Territories, 2023 (%)

Aesthetic Devices Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the aesthetic devices pipeline market, download a free report sample

Aesthetic Devices Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths followed by the aesthetic devices pipeline products are 510(k), CE, PMA, NMPA, NIFDS, TGA, HAS, and ICAC among others. As of May 2023, the most deployed regulatory path for the aesthetic devices market was 510(k).

Aesthetic Devices Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Aesthetic Devices Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Aesthetic Devices pipeline market, download a free report sample

Aesthetic Devices Pipeline Market – Competitive Landscape

Some of the leading companies in the Aesthetic Devices pipeline reconstruction market 3D Bio Corp, AbbVie Inc, Allergan Aesthetics, Candela Corp, and Dexlevo among others.

3D Bio Corp: 3D Bio Corp (3D Bio) is a biologics and bioprinting company. The company operates as a biotechnology company that specializes in regenerative medicine and devices. The company’s pipeline products includes AuriNovo, AnnuNovo, DiscNovo and NasaNovo. The company provides bio printing platform which focuses on whole tissue living implants for near term indications. It has lab and factory facilities in Ithaca, New York and engineering workshop in Brooklyn, New York. The company was funded by Kairos Ventures. 3D Bio is headquartered in New York, the US.

Segments Covered in the Report

Aesthetic Devices Pipeline Market Segments Outlook

  • Aesthetic Injectables
  • Hyaluronic Acid Fillers
  • Aesthetic Laser
  • Implants
  • Others

Aesthetic Devices Pipeline Market Territories Outlook

  • United States
  • Europe
  • China
  • Global
  • South Korea
  • Israel
  • Australia
  • Singapore
  • Japan
  • India
  • Brazil
  • Taiwan
  • Mexico
  • Canada
  • Vietnam
  • Malaysia
  • Indonesia
  • Hong Kong
  • Argentina
  • United Kingdom
  • New Zealand
  • Germany
  • Colombia
  • Costa Rica
  • Ecuador
  • Egypt
  • El Salvador
  • Chile
  • Iran
  • Philippines
  • Russia
  • Saudi Arabia
  • Thailand
  • Turkey

Aesthetic Devices Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • PMA
  • NMPA
  • NIFDS
  • TGA
  • HSA
  • ICAC
  • ANVISA
  • BOPA
  • Ninsho
  • MDITAC
  • MDL
  • MDA
  • MDCO
  • INVIMA
  • UKCA
  • Shonin

Scope

  • Extensive coverage of the Aesthetic Devices under development
  • Reviews details of major pipeline reconstruction which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of Aesthetic Devices and list all their pipeline projects
  • The coverage of pipeline reconstruction based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Aesthetic Devices under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3D Bio Corp
AbbVie Inc
Acro Biomedical Co Ltd
Advanced Aesthetic Technologies Inc
Aeon Astron Corporation
Aesthetic Medical Device
Aesthetics BioMedical, Inc.
Aesthetics Point Ltd.
AirXpanders, Inc.
Allergan Aesthetics
Almirall Ltd
Ambicare Health Ltd
AngioDynamics Inc
Apex Medical Device Design LLC
Arula Technolgies
Asymmetric Medical Ltd
B2M Medical Inc
Bausch Health Companies Inc
Becton Dickinson and Co
Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd
Beijing MeiYan KongJian Technology Co Ltd
BellaSeno GmbH
BellaSeno Pty Ltd
Bimini Health Technologies
BioPlus Co Ltd
Biosculpture Technology, Inc.
Biostruxs LLC
Bioxis Pharmaceuticals
BMG Pharma SpA
Bmi Korea Co Ltd
Boston Scientific Corp
Candela Corp
CellPraxis
Celltrix AB
Clearbridge Health Ltd
ClearIt LLC
Collplant Biotechnologies Ltd
Cutera Inc
Cytrellis Biosystems Inc
Delft University of Technology
Dexlevo Inc
Dongkook Pharmaceutical Co Ltd
Emory University
Endomimetics LLC
EP Global Communications Inc (Inactive)
Erchonia Corp
Establishment Labs SA
Eternity Healthcare Inc
EternoGen Aesthetics LLC
Excita Medical
Fillmed Laboratoires
FixNip Ltd
Florida International University
Forticell Bioscience Inc
Fourth State Medicine Ltd
Fumailei Medical Technology Co Ltd
G2GBIO Inc
Galderma SA
GC Aesthetics Plc
Genial Light Co Ltd
Genzyme Corp
Giant Biogene Holding Co Ltd
Hallura Ltd
HansBiomed Co Ltd
Healshape SAS
Histogen Inc
Hugel Inc
Ilooda Co Ltd
ImpLite Ltd.
InMode Ltd
Innova Medical Design
Innovia LLC
inSoma Bio Inc
Intuitive Surgical Inc
Inventage Lab Inc
Jinwoo Bio Co Ltd
Jointechlabs Inc
Juvenis Ltd
Khorionyx SA
Laboratoires Vivacy SAS
Lattice Medical
Lavish
LG Chem Ltd
LifeCell Corp
LifeSprout Inc
LigthSense Israel Ltd
ManaMed Inc
Medality Medical LLC
Medifirst Solutions Inc
Medytox Inc
Mentor Worldwide LLC
Merz North America Inc
Merz Pharma GmbH & Co KgaA
Mesoestetic Pharma Group SL
Moma Therapeutics Inc
N8 Medical LLC
Nanjing Premier Medical Technology Co Ltd
NanoVibronix Inc
National Healthcare Group
Neosthetic, LLC
NivaSonix, LLC
Northwestern University
Nu Skin International Inc.
Oligo Medic Inc
Osteopore International Pte Ltd
Oxtex Ltd (Inactive)
Pantec Biosolutions AG
PB&B SA
Peptron Inc
PetVivo Holdings Inc
Philips Healthcare
PhotoDerma SA
PhotoMedex Inc
PhotoSonix Medical, Inc.
Pinnacle Therapeutics
Plcoskin
PolyNovo Biomaterials Pty Ltd
Pongkece (Shanghai) Intelligent Medical Technology Co Ltd
Prayasta 3D Inventions Pvt Ltd
Precise Bio Ltd
PS Advanced Engineering
Q-Med AB
Ra Medical Systems Inc
Recros Medica Inc
RepliCel Life Sciences Inc
Samyang Biopharmaceuticals Corp
SANUWAVE Health Inc
Sebana Medical Ltd
Shanghai Haohai Biological Technology Co Ltd
Shanghai Liuqiang Medical Technology Co Ltd
Shenzhen Zhongke Weiguang Medical Device Technology Co Ltd
Shin Poong Pharm Co Ltd
Sienna Biopharmaceuticals Inc (Inactive)
Sientra Inc
Sihuan Pharmaceutical Holdings Group Ltd
Silk Medical Aesthetics Inc
Sinclair Pharma Ltd
Slender Medical Ltd.
SMSbiotech Inc
Sofregen Medical Inc
SofWave Medical Ltd
Soliton Inc
Solta Medical Inc
Southern Illinois University Carbondale
STRATA Skin Sciences Inc
SunMax Biotechnology Co Ltd
Symatese Aesthetics
TEI Biosciences Inc
Tempo Therapeutics Inc
Tensive SRL
Teoxane SA
Tetratherix Pty Ltd
TeVido BioDevices LLC
Tissue Regeneration Technologies LLC
Tissueform Inc
University of California Irvine
University of California Santa Barbara
University of Missouri
University of Pittsburgh
University of Texas at Austin
Uronext LLC
USkin Ltd
Vanderbilt University
Venus Concept Inc
VisageX Medical Ltd
Wuhan Tianshiwei Holdings Co Ltd
Xi'an Lanji Medical Electronic Technology Co Ltd
Zeltiq Aesthetics Inc
Zift Medical LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 13

|1.2 List of Figures 30

2 Introduction 31

2.1 Aesthetic Devices Overview 31

3 Products under Development 33

3.1 Aesthetic Devices – Pipeline Products by Stage of Development 33

3.2 Aesthetic Devices – Pipeline Products by Segment 34

3.3 Aesthetic Devices – Pipeline Products by Territory 36

3.4 Aesthetic Devices – Pipeline Products by Regulatory Path 38

3.5 Aesthetic Devices – Pipeline Products by Estimated Approval Date 39

3.6 Aesthetic Devices – Ongoing Clinical Trials 40

4 Aesthetic Devices – Pipeline Products under Development by Companies 41

4.1 Aesthetic Devices Companies – Pipeline Products by Stage of Development 41

4.2 Aesthetic Devices – Pipeline Products by Stage of Development 48

5 Aesthetic Devices Companies and Product Overview 56

5.1 3D Bio Corp Company Overview 56

5.1.1 3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 56

5.2 AbbVie Inc Company Overview 57

5.2.1 AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.3 Acro Biomedical Co Ltd Company Overview 58

5.3.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.4 Advanced Aesthetic Technologies Inc Company Overview 59

5.4.1 Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.5 Aeon Astron Corporation Company Overview 64

5.5.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 64

5.6 Aesthetic Medical Device Company Overview 66

5.6.1 Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 66

5.7 Aesthetics BioMedical, Inc. Company Overview 69

5.7.1 Aesthetics BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69

5.8 Aesthetics Point Ltd. Company Overview 70

5.8.1 Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70

5.9 AirXpanders, Inc. Company Overview 71

5.9.1 AirXpanders, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

5.10 Allergan Aesthetics Company Overview 72

5.10.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 72

5.11 Almirall Ltd Company Overview 87

5.11.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 87

5.12 Ambicare Health Ltd Company Overview 88

5.12.1 Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 88

5.13 AngioDynamics Inc Company Overview 89

5.13.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.14 Apex Medical Device Design LLC Company Overview 90

5.14.1 Apex Medical Device Design LLC Pipeline Products & Ongoing Clinical Trials Overview 90

5.15 Arula Technolgies Company Overview 91

5.15.1 Arula Technolgies Pipeline Products & Ongoing Clinical Trials Overview 91

5.16 Asymmetric Medical Ltd Company Overview 92

5.16.1 Asymmetric Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 92

5.17 B2M Medical Inc Company Overview 93

5.17.1 B2M Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 93

5.18 Bausch Health Companies Inc Company Overview 94

5.18.1 Bausch Health Companies Inc Pipeline Products & Ongoing Clinical Trials Overview 94

5.19 Becton Dickinson and Co Company Overview 97

5.19.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 97

5.20 Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd Company Overview 98

5.20.1 Beijing Meibo Pharmaceutical Biotechnology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

5.21 Beijing MeiYan KongJian Technology Co Ltd Company Overview 99

5.21.1 Beijing MeiYan KongJian Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 99

5.22 BellaSeno GmbH Company Overview 102

5.22.1 BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 102

5.23 BellaSeno Pty Ltd Company Overview 105

5.23.1 BellaSeno Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

5.24 Bimini Health Technologies Company Overview 108

5.24.1 Bimini Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 108

5.25 BioPlus Co Ltd Company Overview 111

5.25.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 111

5.26 Biosculpture Technology, Inc. Company Overview 114

5.26.1 Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114

5.27 Biostruxs LLC Company Overview 116

5.27.1 Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 116

5.28 Bioxis Pharmaceuticals Company Overview 117

5.28.1 Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 117

5.29 BMG Pharma SpA Company Overview 120

5.29.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 120

5.30 Bmi Korea Co Ltd Company Overview 122

5.30.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 122

5.31 Boston Scientific Corp Company Overview 123

5.31.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 123

5.32 Candela Corp Company Overview 125

5.32.1 Candela Corp Pipeline Products & Ongoing Clinical Trials Overview 125

5.33 CellPraxis Company Overview 126

5.33.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 126

5.34 Celltrix AB Company Overview 127

5.34.1 Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 127

5.35 Clearbridge Health Ltd Company Overview 128

5.35.1 Clearbridge Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 128

5.36 ClearIt LLC Company Overview 129

5.36.1 ClearIt LLC Pipeline Products & Ongoing Clinical Trials Overview 129

5.37 Collplant Biotechnologies Ltd Company Overview 130

5.37.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

5.38 Cutera Inc Company Overview 134

5.38.1 Cutera Inc Pipeline Products & Ongoing Clinical Trials Overview 134

5.39 Cytrellis Biosystems Inc Company Overview 137

5.39.1 Cytrellis Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 137

5.40 Delft University of Technology Company Overview 140

5.40.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 140

5.41 Dexlevo Inc Company Overview 141

5.41.1 Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 141

5.42 Dongkook Pharmaceutical Co Ltd Company Overview 142

5.42.1 Dongkook Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 142

5.43 Emory University Company Overview 145

5.43.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 145

5.44 Endomimetics LLC Company Overview 146

5.44.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 146

5.45 EP Global Communications Inc (Inactive) Company Overview 147

5.45.1 EP Global Communications Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 147

5.46 Erchonia Corp Company Overview 148

5.46.1 Erchonia Corp Pipeline Products & Ongoing Clinical Trials Overview 148

5.47 Establishment Labs SA Company Overview 151

5.47.1 Establishment Labs SA Pipeline Products & Ongoing Clinical Trials Overview 151

5.48 Eternity Healthcare Inc Company Overview 166

5.48.1 Eternity Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 166

5.49 EternoGen Aesthetics LLC Company Overview 167

5.49.1 EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 167

5.50 Excita Medical Company Overview 168

5.50.1 Excita Medical Pipeline Products & Ongoing Clinical Trials Overview 168

5.51 Fillmed Laboratoires Company Overview 169

5.51.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 169

5.52 FixNip Ltd Company Overview 171

5.52.1 FixNip Ltd Pipeline Products & Ongoing Clinical Trials Overview 171

5.53 Florida International University Company Overview 172

5.53.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 172

5.54 Forticell Bioscience Inc Company Overview 173

5.54.1 Forticell Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 173

5.55 Fourth State Medicine Ltd Company Overview 174

5.55.1 Fourth State Medicine Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

5.56 Fumailei Medical Technology Co Ltd Company Overview 175

5.56.1 Fumailei Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 175

5.57 G2GBIO Inc Company Overview 177

5.57.1 G2GBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 177

5.58 Galderma SA Company Overview 178

5.58.1 Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 178

5.59 GC Aesthetics Plc Company Overview 179

5.59.1 GC Aesthetics Plc Pipeline Products & Ongoing Clinical Trials Overview 179

5.60 Genial Light Co Ltd Company Overview 180

5.60.1 Genial Light Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 180

5.61 Genzyme Corp Company Overview 181

5.61.1 Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 181

5.62 Giant Biogene Holding Co Ltd Company Overview 182

5.62.1 Giant Biogene Holding Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

5.63 Hallura Ltd Company Overview 185

5.63.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 185

5.64 HansBiomed Co Ltd Company Overview 187

5.64.1 HansBiomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 187

5.65 Healshape SAS Company Overview 190

5.65.1 Healshape SAS Pipeline Products & Ongoing Clinical Trials Overview 190

5.66 Histogen Inc Company Overview 191

5.66.1 Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 191

5.67 Hugel Inc Company Overview 192

5.67.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 192

5.68 Ilooda Co Ltd Company Overview 196

5.68.1 Ilooda Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 196

5.69 ImpLite Ltd. Company Overview 197

5.69.1 ImpLite Ltd. Pipeline Products & Ongoing Clinical Trials Overview 197

5.70 InMode Ltd Company Overview 198

5.70.1 InMode Ltd Pipeline Products & Ongoing Clinical Trials Overview 198

5.71 Innova Medical Design Company Overview 202

5.71.1 Innova Medical Design Pipeline Products & Ongoing Clinical Trials Overview 202

5.72 Innovia LLC Company Overview 203

5.72.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 203

5.73 inSoma Bio Inc Company Overview 205

5.73.1 inSoma Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 205

5.74 Intuitive Surgical Inc Company Overview 206

5.74.1 Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 206

5.75 Inventage Lab Inc Company Overview 207

5.75.1 Inventage Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 207

5.76 Jinwoo Bio Co Ltd Company Overview 210

5.76.1 Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 210

5.77 Jointechlabs Inc Company Overview 213

5.77.1 Jointechlabs Inc Pipeline Products & Ongoing Clinical Trials Overview 213

5.78 Juvenis Ltd Company Overview 214

5.78.1 Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 214

5.79 Khorionyx SA Company Overview 215

5.79.1 Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 215

5.80 Laboratoires Vivacy SAS Company Overview 216

5.80.1 Laboratoires Vivacy SAS Pipeline Products & Ongoing Clinical Trials Overview 216

5.81 Lattice Medical Company Overview 219

5.81.1 Lattice Medical Pipeline Products & Ongoing Clinical Trials Overview 219

5.82 Lavish Company Overview 222

5.82.1 Lavish Pipeline Products & Ongoing Clinical Trials Overview 222

5.83 LG Chem Ltd Company Overview 225

5.83.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 225

5.84 LifeCell Corp Company Overview 234

5.84.1 LifeCell Corp Pipeline Products & Ongoing Clinical Trials Overview 234

5.85 LifeSprout Inc Company Overview 236

5.85.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 236

5.86 LigthSense Israel Ltd Company Overview 240

5.86.1 LigthSense Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview 240

5.87 ManaMed Inc Company Overview 243

5.87.1 ManaMed Inc Pipeline Products & Ongoing Clinical Trials Overview 243

5.88 Medality Medical LLC Company Overview 244

5.88.1 Medality Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 244

5.89 Medifirst Solutions Inc Company Overview 247

5.89.1 Medifirst Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 247

5.90 Medytox Inc Company Overview 248

5.90.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 248

5.91 Mentor Worldwide LLC Company Overview 252

5.91.1 Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 252

5.92 Merz North America Inc Company Overview 253

5.92.1 Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 253

5.93 Merz Pharma GmbH & Co KgaA Company Overview 256

5.93.1 Merz Pharma GmbH & Co KgaA Pipeline Products & Ongoing Clinical Trials Overview 256

5.94 Mesoestetic Pharma Group SL Company Overview 258

5.94.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 258

5.95 Moma Therapeutics Inc Company Overview 262

5.95.1 Moma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 262

5.96 N8 Medical LLC Company Overview 263

5.96.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 263

5.97 Nanjing Premier Medical Technology Co Ltd Company Overview 264

5.97.1 Nanjing Premier Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 264

5.98 NanoVibronix Inc Company Overview 266

5.98.1 NanoVibronix Inc Pipeline Products & Ongoing Clinical Trials Overview 266

5.99 National Healthcare Group Company Overview 267

5.99.1 National Healthcare Group Pipeline Products & Ongoing Clinical Trials Overview 267

5.100 Neosthetic, LLC Company Overview 268

5.100.1 Neosthetic, LLC Pipeline Products & Ongoing Clinical Trials Overview 268

5.101 NivaSonix, LLC Company Overview 269

5.101.1 NivaSonix, LLC Pipeline Products & Ongoing Clinical Trials Overview 269

5.102 Northwestern University Company Overview 270

5.102.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 270

5.103 Nu Skin International Inc. Company Overview 271

5.103.1 Nu Skin International Inc. Pipeline Products & Ongoing Clinical Trials Overview 271

5.104 Oligo Medic Inc Company Overview 273

5.104.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 273

5.105 Osteopore International Pte Ltd Company Overview 274

5.105.1 Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 274

5.106 Oxtex Ltd (Inactive) Company Overview 277

5.106.1 Oxtex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 277

5.107 Pantec Biosolutions AG Company Overview 279

5.107.1 Pantec Biosolutions AG Pipeline Products & Ongoing Clinical Trials Overview 279

5.108 PB&B SA Company Overview 280

5.108.1 PB&B SA Pipeline Products & Ongoing Clinical Trials Overview 280

5.109 Peptron Inc Company Overview 281

5.109.1 Peptron Inc Pipeline Products & Ongoing Clinical Trials Overview 281

5.110 PetVivo Holdings Inc Company Overview 282

5.110.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 282

5.111 Philips Healthcare Company Overview 284

5.111.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 284

5.112 PhotoDerma SA Company Overview 285

5.112.1 PhotoDerma SA Pipeline Products & Ongoing Clinical Trials Overview 285

5.113 PhotoMedex Inc Company Overview 287

5.113.1 PhotoMedex Inc Pipeline Products & Ongoing Clinical Trials Overview 287

5.114 PhotoSonix Medical, Inc. Company Overview 289

5.114.1 PhotoSonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 289

5.115 Pinnacle Therapeutics Company Overview 290

5.115.1 Pinnacle Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 290

5.116 Plcoskin Company Overview 291

5.116.1 Plcoskin Pipeline Products & Ongoing Clinical Trials Overview 291

5.117 PolyNovo Biomaterials Pty Ltd Company Overview 292

5.117.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 292

5.118 Pongkece (Shanghai) Intelligent Medical Technology Co Ltd Company Overview 295

5.118.1 Pongkece (Shanghai) Intelligent Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 295

5.119 Prayasta 3D Inventions Pvt Ltd Company Overview 296

5.119.1 Prayasta 3D Inventions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 296

5.120 Precise Bio Ltd Company Overview 297

5.120.1 Precise Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 297

5.121 PS Advanced Engineering Company Overview 298

5.121.1 PS Advanced Engineering Pipeline Products & Ongoing Clinical Trials Overview 298

5.122 Q-Med AB Company Overview 300

5.122.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 300

5.123 Ra Medical Systems Inc Company Overview 305

5.123.1 Ra Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 305

5.124 Recros Medica Inc Company Overview 306

5.124.1 Recros Medica Inc Pipeline Products & Ongoing Clinical Trials Overview 306

5.125 RepliCel Life Sciences Inc Company Overview 311

5.125.1 RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 311

5.126 Samyang Biopharmaceuticals Corp Company Overview 312

5.126.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 312

5.127 SANUWAVE Health Inc Company Overview 315

5.127.1 SANUWAVE Health Inc Pipeline Products & Ongoing Clinical Trials Overview 315

5.128 Sebana Medical Ltd Company Overview 318

5.128.1 Sebana Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 318

5.129 Shanghai Haohai Biological Technology Co Ltd Company Overview 319

5.129.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 319

5.130 Shanghai Liuqiang Medical Technology Co Ltd Company Overview 321

5.130.1 Shanghai Liuqiang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 321

5.131 Shenzhen Zhongke Weiguang Medical Device Technology Co Ltd Company Overview 322

5.131.1 Shenzhen Zhongke Weiguang Medical Device Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 322

5.132 Shin Poong Pharm Co Ltd Company Overview 323

5.132.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 323

5.133 Sienna Biopharmaceuticals Inc (Inactive) Company Overview 324

5.133.1 Sienna Biopharmaceuticals Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 324

5.134 Sientra Inc Company Overview 327

5.134.1 Sientra Inc Pipeline Products & Ongoing Clinical Trials Overview 327

5.135 Sihuan Pharmaceutical Holdings Group Ltd Company Overview 329

5.135.1 Sihuan Pharmaceutical Holdings Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 329

5.136 Silk Medical Aesthetics Inc Company Overview 330

5.136.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 330

5.137 Sinclair Pharma Ltd Company Overview 334

5.137.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 334

5.138 Slender Medical Ltd. Company Overview 338

5.138.1 Slender Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 338

5.139 SMSbiotech Inc Company Overview 340

5.139.1 SMSbiotech Inc Pipeline Products & Ongoing Clinical Trials Overview 340

5.140 Sofregen Medical Inc Company Overview 341

5.140.1 Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 341

5.141 SofWave Medical Ltd Company Overview 344

5.141.1 SofWave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 344

5.142 Soliton Inc Company Overview 349

5.142.1 Soliton Inc Pipeline Products & Ongoing Clinical Trials Overview 349

5.143 Solta Medical Inc Company Overview 356

5.143.1 Solta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 356

5.144 Southern Illinois University Carbondale Company Overview 358

5.144.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 358

5.145 STRATA Skin Sciences Inc Company Overview 359

5.145.1 STRATA Skin Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 359

5.146 SunMax Biotechnology Co Ltd Company Overview 362

5.146.1 SunMax Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 362

5.147 Symatese Aesthetics Company Overview 367

5.147.1 Symatese Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 367

5.148 TEI Biosciences Inc Company Overview 370

5.148.1 TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 370

5.149 Tempo Therapeutics Inc Company Overview 371

5.149.1 Tempo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 371

5.150 Tensive SRL Company Overview 372

5.150.1 Tensive SRL Pipeline Products & Ongoing Clinical Trials Overview 372

5.151 Teoxane SA Company Overview 375

5.151.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 375

5.152 Tetratherix Pty Ltd Company Overview 379

5.152.1 Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 379

5.153 TeVido BioDevices LLC Company Overview 380

5.153.1 TeVido BioDevices LLC Pipeline Products & Ongoing Clinical Trials Overview 380

5.154 Tissue Regeneration Technologies LLC Company Overview 381

5.154.1 Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 381

5.155 Tissueform Inc Company Overview 382

5.155.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 382

5.156 University of California Irvine Company Overview 383

5.156.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 383

5.157 University of California Santa Barbara Company Overview 384

5.157.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 384

5.158 University of Missouri Company Overview 385

5.158.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 385

5.159 University of Pittsburgh Company Overview 386

5.159.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 386

5.160 University of Texas at Austin Company Overview 387

5.160.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 387

5.161 Uronext LLC Company Overview 390

5.161.1 Uronext LLC Pipeline Products & Ongoing Clinical Trials Overview 390

5.162 USkin Ltd Company Overview 391

5.162.1 USkin Ltd Pipeline Products & Ongoing Clinical Trials Overview 391

5.163 Vanderbilt University Company Overview 392

5.163.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 392

5.164 Venus Concept Inc Company Overview 393

5.164.1 Venus Concept Inc Pipeline Products & Ongoing Clinical Trials Overview 393

5.165 VisageX Medical Ltd Company Overview 397

5.165.1 VisageX Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 397

5.166 Wuhan Tianshiwei Holdings Co Ltd Company Overview 398

5.166.1 Wuhan Tianshiwei Holdings Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 398

5.167 Xi’an Lanji Medical Electronic Technology Co Ltd Company Overview 399

5.167.1 Xi’an Lanji Medical Electronic Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 399

5.168 Zeltiq Aesthetics Inc Company Overview 400

5.168.1 Zeltiq Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 400

5.169 Zift Medical LLC Company Overview 407

5.169.1 Zift Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 407

6 Aesthetic Devices- Recent Developments 410

7 Appendix

Frequently asked questions

Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.